EUVIMEDEUVIMED entdecken
Crossref

CRISPR-Cas Systems: From Bacterial BiochemistrytoBiomedical Revolution—A Review of Mechanisms, Delivery Challenges, and Therapeutic Gene Editing

Narendar Bhojak, Sanjeeta Nayak, Supriyo Acharya

IFR Journal of Biochemistry and Biomedical Science · 01.03.2026 · 2 (1) · 21-29

DOI: 10.70146/bbsv02i01.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IFR Journal of Biochemistry and Biomedical Science, erschienen am 01.03.2026. Verfasst von Narendar Bhojak und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CRISPR, Cas genome editing platform has revolutionised modern biomedical science offeringthe possibility to precisely and programmably modify the genome. Derived from the adaptive immune systemsof bacteria and archaea, CRISPR, Cas machinery has been ingeniously reconfigured to achieve DNAand RNAediting with record efficiency and versatility. This article delivers a detailed exposition of the molecular bases of CRISPR, Cas, based technologies and tracks their journey from a simple study of bacterial metabolismtothedevelopment of highly sophisticated therapeutic agents. We cover the range of CRISPR systemfunctionality, with Cas9, Cas12, Cas13, base editors, prime editors, and the latest transposon, associated editors, eachcontrasted for their mechanisms of action and relevance to biomedicine. The review also takes a close lookat different techniques for delivering CRISPR ingredients nowadays and pits viral against non, viral deliverymethods in terms of their efficiency, specificity, and safety aspects. Brainstorming issues for therapy like off, target effects, immune responses, and delivery obstacles in living organisms (in vivo) are highlighted. The useof gene, editing tools discusses various diseases such as a cancer, single, gene disorders, infectious diseases, andimmune system diseases and the results of animal studies as well as human trials are evidenced. Thecombination of more efficient guide RNA, the use of high, fidelity Cas variants, and the development of transient editing systems, has marked a substantial move forward in increasing the accuracy and minimizingtheunintended genomic changes. In summary, this review sheds light on how quickly the CRISPR, Castechnologies matured and how their role in precision medicine keeps growing. To tap into the full clinical potential of CRISPR, based gene therapies, it will be crucial to keep innovating in editing accuracy, deliverysystems, and regulatory frameworks.

Zitieren

APA

Bhojak, N., Nayak, S., & Acharya, S. (2026). CRISPR-Cas Systems: From Bacterial BiochemistrytoBiomedical Revolution—A Review of Mechanisms, Delivery Challenges, and Therapeutic Gene Editing. IFR Journal of Biochemistry and Biomedical Science, 2(1), 21-29. https://doi.org/10.70146/bbsv02i01.003

Vancouver

Bhojak N, Nayak S, Acharya S. CRISPR-Cas Systems: From Bacterial BiochemistrytoBiomedical Revolution—A Review of Mechanisms, Delivery Challenges, and Therapeutic Gene Editing. IFR Journal of Biochemistry and Biomedical Science. 2026;2(1):21-29. doi:10.70146/bbsv02i01.003

BibTeX
@article{Bhojak2026,
  author = {Bhojak, Narendar and Nayak, Sanjeeta and Acharya, Supriyo},
  title = {CRISPR-Cas Systems: From Bacterial BiochemistrytoBiomedical Revolution—A Review of Mechanisms, Delivery Challenges, and Therapeutic Gene Editing},
  journal = {IFR Journal of Biochemistry and Biomedical Science},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {21--29},
  doi = {10.70146/bbsv02i01.003}
}
Kostenlos starten →